Literature DB >> 11994281

Effective information transfer from the alpha 1b-adrenoceptor to Galpha 11 requires both beta/gamma interactions and an aromatic group four amino acids from the C terminus of the G protein.

Sen Liu1, Juan J Carrillo, John D Pediani, Graeme Milligan.   

Abstract

Co-expression of the alpha(1b)-adrenoreceptor and Galpha(11) in cells derived from a Galpha(q)/Galpha(11) knock-out mouse allows agonist-mediated elevation of intracellular Ca(2+) levels that is transduced by beta/gamma released from the G protein alpha subunit. Mutation of Tyr(356) of Galpha(11) to Phe, within a receptor contact domain, had little effect on function but this was reduced greatly by alteration to Ser and virtually eliminated by conversion to Asp. This pattern was replicated following incorporation of each form of Galpha(11) into fusion proteins with the alpha(1b)-adrenoreceptor. Following a [(35)S]guanosine 5'-O-(3-thiotriphosphate) (GTPgammaS) binding assay, immunoprecipitation of the wild type alpha(1b)-adrenoreceptor-Galpha(11) fusion protein indicated that the agonist phenylephrine stimulated guanine nucleotide exchange on Galpha(11) more than 30-fold. Information transfer by agonist was controlled in residue 356 Galpha(11) mutants with rank order Tyr > Phe > Trp > Ile > Ala = Gln = Arg > Ser > Asp, although these alterations did not alter the binding affinity of either phenylephrine or an antagonist ligand. Mutation of a beta/gamma contact interface in the alpha(1b)-adrenoreceptor-Tyr(356) Galpha(11) fusion protein did not alter ligand binding affinity but did reduce greatly beta/gamma binding and phenylephrine stimulation of [(35)S]GTPgammaS binding. It also prevented agonist elevation of intracellular Ca(2+) levels, as did a mutation in Galpha(11) that prevents G protein subunit dissociation. These results indicate that a bulky aromatic group is required four amino acids from the C terminus of Galpha(11) to maximize information transfer from an agonist-occupied receptor and disprove the hypothesis that tyrosine phosphorylation of this residue is required for G protein activation (Umemori, H., Inoue, T., Kume, S., Sekiyama, N., Nagao, M., Itoh, H., Nakanishi, S., Mikoshiba, K., and Yamamoto, T. (1997) Science 276, 1878-1881). This is distinct from Galpha(i1), where hydrophobicity of the amino acid is the key determinant at this location. They also further demonstrate a key role for the beta/gamma complex in enhancing receptor to G protein alpha subunit information transfer.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11994281     DOI: 10.1074/jbc.M201015200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  5 in total

1.  The sustainability of interactions between the orexin-1 receptor and beta-arrestin-2 is defined by a single C-terminal cluster of hydroxy amino acids and modulates the kinetics of ERK MAPK regulation.

Authors:  Sandra Milasta; Nicholas A Evans; Laura Ormiston; Shelagh Wilson; Robert J Lefkowitz; Graeme Milligan
Journal:  Biochem J       Date:  2005-05-01       Impact factor: 3.857

2.  Regulation of the avidity of ternary complexes containing the human 5-HT(1A) receptor by mutation of a receptor contact site on the interacting G protein alpha subunit.

Authors:  Philip J Welsby; I Craig Carr; Graeme Wilkinson; Graeme Milligan
Journal:  Br J Pharmacol       Date:  2002-10       Impact factor: 8.739

3.  The M1 muscarinic receptor is present in situ as a ligand-regulated mixture of monomers and oligomeric complexes.

Authors:  Sara Marsango; Laura Jenkins; John D Pediani; Sophie J Bradley; Richard J Ward; Sarah Hesse; Gabriel Biener; Michael R Stoneman; Andrew B Tobin; Valerica Raicu; Graeme Milligan
Journal:  Proc Natl Acad Sci U S A       Date:  2022-06-07       Impact factor: 12.779

Review 4.  Structure, Function, Pharmacology, and Therapeutic Potential of the G Protein, Gα/q,11.

Authors:  Danielle Kamato; Lyna Thach; Rebekah Bernard; Vincent Chan; Wenhua Zheng; Harveen Kaur; Margaret Brimble; Narin Osman; Peter J Little
Journal:  Front Cardiovasc Med       Date:  2015-03-24

5.  The protein kinase C inhibitor, Ro-31-7459, is a potent activator of ERK and JNK MAP kinases in HUVECs and yet inhibits cyclic AMP-stimulated SOCS-3 gene induction through inactivation of the transcription factor c-Jun.

Authors:  Jolanta Wiejak; Julia Dunlop; Chloe Stoyle; Gillian Lappin; Anna McIlroy; John D Pediani; Shan Gao; Stephen J Yarwood
Journal:  Cell Signal       Date:  2012-04-25       Impact factor: 4.315

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.